Erythropoiesis-Stimulating Agents Do Not Adversely Affect Long-Term Outcomes Nor Increase the Risk of Thromboembolic Events in Multiple Myeloma Patients Treated in the Phase III VISTA Trial.
| Autor: | Richardson, Paul, Schlag, Rudolf *, Khuageva, Nuriet K *, Dimopoulos, Meletios A., Shpilberg, Ofer *, Kropff, Martin H, Delforge, Michel, Petrucci, Maria Teresa, Rossiev, Victor A *, Hou, Jian *, Robak, Tadeusz, Mateos, Maria-Victoria *, Anderson, Kenneth C., Cakana, Andrew, Liu, Kevin *, Deraedt, William *, van de Velde, Helgi *, San Miguel, Jesus F. |
|---|---|
| Zdroj: | In Blood 16 November 2008 112(11):1741-1741 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|